title: Cost-Effectiveness of Ranibizumab Versus Photodynamic Therapy for the Treatment of Neovascluar Age-Related Macular Degeneration Based in China Cost Setting.
authors.affiliation: Fudan University, China, Shanghai, China.
authors.forename: S
authors.initials: S
authors.lastname: Feng
authors.affiliation: Fudan University, China, Shanghai, China.
authors.forename: X
authors.initials: X
authors.lastname: Ying
authors.affiliation: Fudan University, China, Shanghai, China.
authors.forename: F
authors.initials: F
authors.lastname: Qi
authors.affiliation: Beijing Novartis Pharma Co., Ltd, Beijing, China.
authors.forename: J
authors.initials: J
authors.lastname: Chang